2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning (2023)

Peer-Reviewed Study · Lavonas EJ, Akpunonu PD, Arens AM, Babu KM, Cao D, Hoffman RS, Hoyte CO, Mazer-Amirshahi ME, et al. · October 17, 2023

Lavonas EJ et al., 2023-10-17: Current U.S. resuscitation guideline naming hydroxocobalamin as the preferred cyanide antidote, with sodium nitrite plus sodium thiosulfate as the alternative, and stating that methylene blue is not supported by sufficient evidence for a recommendation.

If cyanide poisoning is suspected, do not wait for confirmatory testing. Treat immediately with hydroxocobalamin (preferred) or sodium nitrite plus sodium thiosulfate.

e149-e184 (cyanide section)

Lavonas EJ et al., 2023-10-17: Current U.S. resuscitation guideline naming hydroxocobalamin as the preferred cyanide antidote, with sodium nitrite plus sodium thiosulfate as the alternative, and stating that methylene blue is not supported by sufficient evidence for a recommendation. Clinical practice guideline, not a trial. PMID 37721023; DOI 10.1161/CIR.0000000000001161. Full text is paywalled at ahajournals.org; the quoted passages were read in the publisher's PDF copy at emcrit.org (2023 upload of the Circulation article). The guideline also lists methylene blue among 'other nonadrenergic vasopressors … not supported by sufficient evidence to support a recommendation'. AHA declares no relevant financial relationships for the writing group. Study type: review.